Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tustin, CA
SEC filing record 1 source field available
Fiscal year end
30 April
Avid Bioservices, Inc. has filed 1,388 SEC EDGAR filings since 14 Sep 1995

SEC filing history

Showing 901-925 of 992 matching filings.

Per page
25
Current page
37
8-K File 001-32839

FORM 8-K

Filing date
20 Oct 2011
Reporting date
20 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

FORM 8-K

Filing date
09 Sep 2011
Reporting date
09 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-171252

PROSPECTUS SUPPLEMENT 424B5

Filing date
02 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

FORM 8-K

Filing date
02 Sep 2011
Reporting date
02 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-32839

DEFINITIVE ADDITIONAL MATERIALS

Filing date
26 Aug 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-32839

FORM DEF 14A

Filing date
26 Aug 2011
Reporting date
20 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

CURRENT REPORT ON FORM 8-K

Filing date
24 Aug 2011
Reporting date
24 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-32839

PRELIMINARY PROXY STATEMENT

Filing date
12 Aug 2011
Reporting date
20 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-32839

PEREGRINE 10-K

Filing date
14 Jul 2011
Reporting date
30 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

CURRENT REPORT ON FORM 8K

Filing date
14 Jul 2011
Reporting date
14 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jul 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jul 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jul 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jul 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

CURRENT REPORT ON FORM 8-K

Filing date
16 Jun 2011
Reporting date
15 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
31 May 2011
Reporting date
26 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

CURRENT REPORT ON FORM 8K

Filing date
19 May 2011
Reporting date
19 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

PEREGRINE PHARMACEUTICALS, INC.

Filing date
05 May 2011
Reporting date
02 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2011
Reporting date
02 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2011
Reporting date
29 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2011
Reporting date
02 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2011
Reporting date
29 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2011
Reporting date
29 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2011
Reporting date
02 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .